Vitura Health (ASX:VIT) has released its financial report for the half-year ended December 31, 2022, showing significant growth across all key financial metrics.
Vitura Health reported a record gross revenue for H1 2023 of $57.6M, up more than 110% on the previous half-year, as well as $14.8M cash at bank at the end of the half, after payment of $5.5M in dividends.
Vitura Health's CEO Rodney Cocks says it's well positioned to deliver further growth and shareholder value for the remainder of 2023:
"Revenue in this half is 86%, and net profit after tax is 127%, of the same metrics achieved in the full year of FY2022."